Ignite Creation Date:
2024-05-06 @ 6:54 PM
Last Modification Date:
2024-10-26 @ 2:57 PM
Study NCT ID:
NCT05829629
Status:
RECRUITING
Last Update Posted:
2023-09-14
First Post:
2023-04-11
Brief Title:
Phase 1 Dose-escalation Study of FluBHPVE6E7 in HPV16-infected Women
Sponsor:
BlueSky Immunotherapies GmbH
Organization:
BlueSky Immunotherapies GmbH
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-09-12
Start Date Type:
ACTUAL
Primary Completion Date:
2024-09
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-11
Completion Date Type:
ESTIMATED
First Submit Date:
2023-04-11
First Submit QC Date:
April 24 2023
Study First Post Date:
2023-04-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-09-13
Last Update Post Date:
2023-09-14
Last Update Post Date Type:
ACTUAL